Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Quoin Pharmaceuticals, Ltd.
  6. News
  7. Summary
    QNRX   US74907L2016

QUOIN PHARMACEUTICALS, LTD.

(QNRX)
  Report
Delayed Nasdaq  -  04:00 2022-08-12 pm EDT
4.780 USD   -0.83%
08/11Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th
AQ
08/11QUOIN PHARMACEUTICALS : Announces Pricing of $16.8 Million Upsized Public Offering - Form 6-K
PU
08/09Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Rebound Late

07/01/2022 | 04:08pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AGILE THERAPEUTICS, INC. -11.93% 0.565 Delayed Quote.-97.11%
ASTRAZENECA PLC 1.96% 10712 Delayed Quote.23.44%
CERTARA, INC. -13.03% 17.56 Delayed Quote.-38.21%
NASDAQ COMPOSITE 2.09% 13047.19 Real-time Quote.-17.83%
PIPER SANDLER COMPANIES 0.66% 131.88 Delayed Quote.-26.12%
QUOIN PHARMACEUTICALS, LTD. -0.83% 4.78 Delayed Quote.-78.99%
All news about QUOIN PHARMACEUTICALS, LTD.
08/11Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corpo..
AQ
08/11QUOIN PHARMACEUTICALS : Announces Pricing of $16.8 Million Upsized Public Offering - Form ..
PU
08/09Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
AQ
08/05Top Midday Decliners
MT
08/05Quoin Pharmaceuticals Prices Offering of Ordinary Shares, Pre-Funded Warrants; Stock Pl..
MT
08/05Quoin Pharmaceuticals Announces Pricing of $16.8 Million Upsized Public Offering
AQ
08/05Top Premarket Decliners
MT
08/02Top Premarket Gainers
MT
07/28Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for ..
AQ
07/28Quoin Pharmaceuticals Announces Receipt of Constructive Scientific Advice from EMA for ..
CI
More news
Analyst Recommendations on QUOIN PHARMACEUTICALS, LTD.
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -11,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -0,07x
Yield 2022 -
Capitalization 6,86 M 6,86 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 4
Free-Float 0,24%
Chart QUOIN PHARMACEUTICALS, LTD.
Duration : Period :
Quoin Pharmaceuticals, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUOIN PHARMACEUTICALS, LTD.
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 4,78 $
Average target price 52,03 $
Spread / Average Target 989%
EPS Revisions
Managers and Directors
Michael Myers Chairman & Chief Executive Officer
Gordon B. Dunn Chief Financial Officer
Denise Carter Chief Operating Officer & Director
Dennis H. Langer Independent Director
Natalie Leong Independent Director
Sector and Competitors
1st jan.Capi. (M$)
QUOIN PHARMACEUTICALS, LTD.-78.99%7
MODERNA, INC.-32.60%67 212
LONZA GROUP AG-23.32%46 073
IQVIA HOLDINGS INC.-12.88%45 135
SEAGEN INC.10.05%32 099
ALNYLAM PHARMACEUTICALS, INC.37.90%27 533